Cash flow IDEXX Laboratories, Inc.

Stocks

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-08-27 EDT			5-day change	1st Jan Change
545.08 ^USD	-1.51%		-0.14%	-19.43%

08-17	IDEXX Laboratories, Inc. - Analyst/Investor Day
08-11	IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment	MT

2cf52.5JxMwQ0RymsZDAbUx-miD_fhhNDG7GE5-VICzOMCwC8.h84PtERlnQ10dnW58a_KZ9rY8oaCmS9Inw03rpBDs3nRyAOjXEiBWH89YQ

Published financial data: IDEXX LABORATORIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	3.22B	3.37B	3.66B	3.9B	4.3B
Total Revenues	3.22B	3.37B	3.66B	3.9B	4.3B
Cost of Goods Sold, Total	1.33B	1.36B	1.47B	1.52B	1.64B
Gross Profit	1.89B	2B	2.19B	2.38B	2.66B
Selling General & Admin Expenses, Total	796M	851M	902M	969M	1.05B
R&D Expenses	161M	255M	191M	220M	251M
Other Operating Expenses, Total	957M	1.11B	1.09B	1.19B	1.3B
Operating Income	932M	899M	1.1B	1.19B	1.36B
Interest Expense, Total	-29.81M	-39.86M	-41.58M	-31.2M	-38.85M
Interest And Investment Income	434K	1.06M	5.63M	12.7M	3.01M
Net Interest Expenses	-29.37M	-38.79M	-35.95M	-18.51M	-35.84M
EBT, Excl. Unusual Items	903M	860M	1.06B	1.17B	1.32B
Asset Writedown	-	-	-	-	-
Legal Settlements	-	-	-	-61.5M	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	903M	860M	1.06B	1.11B	1.32B
Income Tax Expense	158M	181M	216M	222M	265M
Earnings From Continuing Operations	745M	679M	845M	888M	1.06B
Net Income to Company	745M	679M	845M	888M	1.06B
Minority Interest	1K	-	-	-	-
Net Income - (IS)	745M	679M	845M	888M	1.06B
Net Income to Common Incl Extra Items	745M	679M	845M	888M	1.06B
Net Income to Common Excl. Extra Items	745M	679M	845M	888M	1.06B
Per Share Items
Net EPS - Basic	8.74	8.12	10.17	10.77	13.17
Basic EPS - Continuing Operations	8.74	8.12	10.17	10.77	13.17
Basic Weighted Average Shares Outstanding	85.2M	83.62M	83.07M	82.47M	80.43M
Net EPS - Diluted	8.6	8.03	10.06	10.67	13.08
Diluted EPS - Continuing Operations	8.6	8.03	10.06	10.67	13.08
Diluted Weighted Average Shares Outstanding	86.57M	84.6M	83.98M	83.25M	81.02M
Normalized Basic EPS	6.62	6.43	7.98	8.88	10.29
Normalized Diluted EPS	6.52	6.35	7.9	8.79	10.21
Supplemental Items
EBITDA	1.04B	1.01B	1.21B	1.32B	1.51B
EBITA	944M	914M	1.11B	1.21B	1.38B
EBIT	932M	899M	1.1B	1.19B	1.36B
EBITDAR	1.06B	1.04B	1.24B	1.35B	1.54B
Total Revenues (As Reported)	3.22B	3.37B	3.66B	3.9B	4.3B
Effective Tax Rate - (Ratio)	17.48	21.03	20.37	20	19.99
Current Domestic Taxes	132M	181M	232M	205M	90.93M
Current Foreign Taxes	29.29M	35.14M	32.8M	41M	42.59M
Total Current Taxes	161M	216M	264M	246M	134M
Deferred Domestic Taxes	-7.52M	-37.4M	-42.96M	-29.35M	126M
Deferred Foreign Taxes	4.09M	2.52M	-5.34M	5.16M	5.04M
Total Deferred Taxes	-3.44M	-34.88M	-48.31M	-24.19M	131M
Normalized Net Income	564M	537M	663M	732M	828M
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	-	1.5M	1.1M	1.3M	1.8M
Supplemental Operating Expense Items
Advertising Expense	3.3M	5M	4.2M	3.4M	4M
Selling and Marketing Expenses	487M	525M	566M	589M	644M
General and Administrative Expenses	310M	326M	336M	381M	405M
Research And Development Expense From Footnotes	161M	255M	191M	220M	251M
Net Rental Expense, Total	25.5M	28.7M	31.7M	34M	38.3M
Imputed Operating Lease Interest Expense	5.98M	7.32M	8.31M	8.26M	12.13M
Imputed Operating Lease Depreciation	19.52M	21.38M	23.39M	25.74M	26.17M
Stock-Based Comp., COGS (Total)	4.04M	4.64M	5.64M	6.01M	6.56M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	33.71M	45.13M	54.1M	54.28M	53.46M
Total Stock-Based Compensation	37.76M	49.77M	59.74M	60.3M	60.01M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	144M	113M	454M	288M	180M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	144M	113M	454M	288M	180M
Accounts Receivable, Total	406M	442M	513M	534M	628M
Other Receivables	19.46M	48.43M	16.97M	26.99M	64.98M
Total Receivables	426M	491M	530M	561M	693M
Inventory	269M	368M	380M	382M	378M
Prepaid Expenses	42M	41.74M	48.37M	58.63M	57.9M
Other Current Assets, Total	74.59M	88.46M	83.14M	110M	105M
Total Current Assets	956M	1.1B	1.5B	1.4B	1.41B
Gross Property Plant And Equipment	1.34B	1.47B	1.6B	1.66B	1.8B
Accumulated Depreciation	-648M	-706M	-785M	-835M	-926M
Net Property Plant And Equipment	693M	768M	818M	829M	871M
Long-term Investments	-	30.25M	30.25M	31M	31.76M
Goodwill	359M	362M	366M	405M	414M
Other Intangibles, Total	99.04M	97.67M	84.5M	112M	110M
Accounts Receivable Long-Term	122M	149M	168M	186M	237M
Deferred Tax Assets Long-Term	24.78M	55.22M	107M	126M	27.87M
Deferred Charges Long-Term	122M	120M	-	-	-
Other Long-Term Assets, Total	61.04M	63.37M	191M	205M	246M
Total Assets	2.44B	2.75B	3.26B	3.29B	3.35B
Liabilities
Accounts Payable, Total	116M	110M	111M	114M	110M
Accrued Expenses, Total	396M	360M	372M	418M	414M
Short-term Borrowings	73.5M	579M	250M	250M	398M
Current Portion of Long-Term Debt	75M	74.98M	75M	168M	75M
Current Portion of Leases	19.93M	20.42M	19.8M	21.54M	27.07M
Current Income Taxes Payable	42.6M	48.55M	86.55M	62.25M	88.67M
Unearned Revenue Current, Total	40.03M	37.94M	37.2M	33.8M	35.26M
Other Current Liabilities	601K	4.57M	-	-	-
Total Current Liabilities	764M	1.24B	952M	1.07B	1.15B
Long-Term Debt	775M	694M	623M	450M	375M
Long-Term Leases	87.39M	101M	99.67M	97.84M	101M
Unearned Revenue Non Current	41.17M	30.86M	28.53M	26.94M	32.18M
Deferred Tax Liability Non Current	8.94M	8.15M	7.24M	11.31M	31.86M
Other Non Current Liabilities	70.93M	67.59M	65.53M	44.34M	56.08M
Total Liabilities	1.75B	2.14B	1.78B	1.7B	1.75B
Common Stock, Total	10.69M	10.72M	10.75M	10.78M	10.84M
Additional Paid In Capital	1.38B	1.46B	1.57B	1.67B	1.83B
Retained Earnings	2.92B	3.6B	4.44B	5.33B	6.39B
Treasury Stock	-3.57B	-4.39B	-4.47B	-5.33B	-6.56B
Comprehensive Income and Other	-47.76M	-72.61M	-65.68M	-87.76M	-62.75M
Total Common Equity	690M	609M	1.48B	1.6B	1.61B
Minority Interest	-	-	-	-	-
Total Equity	690M	609M	1.48B	1.6B	1.61B
Total Liabilities And Equity	2.44B	2.75B	3.26B	3.29B	3.35B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	84.25M	82.9M	83.09M	81.33M	79.62M
ECS Total Common Shares Outstanding	84.56M	82.89M	83.03M	81.6M	79.71M
Book Value / Share	8.16	7.34	17.88	19.55	20.14
Tangible Book Value	232M	149M	1.03B	1.08B	1.08B
Tangible Book Value Per Share	2.74	1.8	12.45	13.22	13.57
Total Debt	1.03B	1.47B	1.07B	987M	977M
Net Debt	887M	1.36B	613M	699M	796M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-12.5M	-14.4M	-15.1M	-20.7M
Debt Equivalent Oper. Leases	204M	230M	254M	272M	306M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	60.43M	92.8M	106M	104M	96.3M
Inventories - Work In Process, Total	26.4M	28.04M	28.99M	31.91M	32.59M
Inventories - Finished Goods, Total	182M	247M	245M	246M	249M
Land - (BS)	22.64M	22.22M	22.4M	23.99M	24.64M
Buildings, Total	329M	356M	432M	446M	462M
Machinery, Total	729M	773M	837M	891M	992M
Full Time Employees	10.35K	10.78K	11K	11K	11K
Accumulated Allowance for Doubtful Accounts (Supple)	5.67M	8.26M	9.5M	12.58M	11.3M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	745M	679M	845M	888M	1.06B
Depreciation & Amortization - CF	92.5M	96.9M	101M	113M	125M
Amortization of Goodwill and Intangible Assets - (CF)	12.1M	15M	13.8M	17.1M	20.2M
Depreciation & Amortization, Total	105M	112M	115M	130M	145M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	5.15M	2.35M	1.48M	250K	-
Stock-Based Compensation (CF)	37.76M	49.77M	59.74M	60.3M	60.01M
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	1.48M	5.83M	5.55M	6.87M	8.43M
Other Operating Activities, Total	-759K	-32.42M	-47.79M	-22.98M	136M
Change In Accounts Receivable	-33.14M	-41.4M	-53.87M	-28.28M	-68.72M
Change In Inventories	-52.92M	-122M	-28.65M	-28M	-789K
Change In Accounts Payable	11.23M	3.47M	-557K	8.09M	-8.57M
Change in Unearned Revenues	-7.55M	-11.02M	-3.03M	-4.38M	6.93M
Change in Other Net Operating Assets	-55.14M	-103M	13.68M	-80.66M	-156M
Cash from Operations	756M	543M	907M	929M	1.18B
Capital Expenditure	-120M	-149M	-134M	-121M	-125M
Cash Acquisitions	-173M	-11.51M	-	-76.69M	-
Sale (Purchase) of Intangible assets	-	-10M	-	-10M	-13.55M
Investment in Marketable and Equity Securities, Total	-	-25M	-	-1M	-756K
Other Investing Activities, Total	-	-	8.38M	1.56M	2.74M
Cash from Investing	-293M	-195M	-125M	-207M	-136M
Short Term Debt Issued, Total	-	-	-	-	148M
Long-Term Debt Issued, Total	73.5M	506M	-	-	250M
Total Debt Issued	73.5M	506M	-	-	398M
Short Term Debt Repaid, Total	-	-	-329M	-	-
Long-Term Debt Repaid, Total	-50M	-75M	-75M	-75M	-428M
Total Debt Repaid	-50M	-75M	-404M	-75M	-428M
Issuance of Common Stock	46.56M	35.75M	47.03M	44.49M	93.36M
Repurchase of Common Stock	-762M	-830M	-81.9M	-848M	-1.22B
Other Financing Activities, Total	-5.14M	-6.87M	-3.14M	-	-3.74M
Cash from Financing	-697M	-371M	-442M	-878M	-1.16B
Foreign Exchange Rate Adjustments	-4.64M	-8.61M	2.13M	-9.53M	11.2M
Net Change in Cash	-239M	-31.91M	341M	-166M	-108M
Supplemental Items
Cash Interest Paid	30.5M	39.5M	41M	33.8M	37.7M
Cash Income Tax Paid (Refund)	162M	240M	192M	307M	167M
Levered Free Cash Flow	534M	328M	694M	735M	791M
Unlevered Free Cash Flow	553M	353M	720M	754M	815M
Change In Net Working Capital	52.28M	211M	7.04M	48.47M	102M
Net Debt Issued / Repaid	23.5M	430M	-404M	-75M	-30.38M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	24.62	21.67	22.83	22.7	25.59
Return on Total Capital	34.7	29.57	29.62	28.97	32.92
Return On Equity %	112.62	104.58	80.74	57.66	66.2
Return on Common Equity	112.68	104.58	80.74	57.66	66.2
Margin Analysis
Gross Profit Margin %	58.76	59.52	59.82	61.04	61.8
SG&A Margin	24.77	25.26	24.64	24.87	24.36
EBITDA Margin %	32.24	30.01	33.11	33.86	34.97
EBITA Margin %	29.36	27.14	30.35	30.97	32.07
EBIT Margin %	28.99	26.69	29.97	30.53	31.6
Income From Continuing Operations Margin %	23.17	20.17	23.08	22.78	24.62
Net Income Margin %	23.17	20.17	23.08	22.78	24.62
Net Avail. For Common Margin %	23.17	20.17	23.08	22.78	24.62
Normalized Net Income Margin	17.55	15.96	18.12	18.78	19.23
Levered Free Cash Flow Margin	16.62	9.75	18.95	18.86	18.37
Unlevered Free Cash Flow Margin	17.2	10.49	19.66	19.36	18.94
Asset Turnover
Asset Turnover	1.36	1.3	1.22	1.19	1.3
Fixed Assets Turnover	4.8	4.61	4.62	4.73	5.06
Receivables Turnover (Average Receivables)	8.45	7.94	7.67	7.45	7.4
Inventory Turnover (Average Inventory)	5.54	4.28	3.93	3.98	4.33
Short Term Liquidity
Current Ratio	1.25	0.89	1.57	1.31	1.23
Quick Ratio	0.75	0.49	1.03	0.8	0.76
Operating Cash Flow to Current Liabilities	0.99	0.44	0.95	0.87	1.03
Days Sales Outstanding (Average Receivables)	43.22	45.99	47.61	49.15	49.3
Days Outstanding Inventory (Average Inventory)	65.92	85.27	92.81	91.85	84.32
Average Days Payable Outstanding	25.13	28.26	27.17	27.07	25
Cash Conversion Cycle (Average Days)	84	103	113.25	113.93	108.62
Long Term Solvency
Total Debt/Equity	149.43	241.49	71.9	61.87	60.83
Total Debt / Total Capital	59.91	70.72	41.83	38.22	37.82
LT Debt/Equity	125.02	130.7	48.67	34.33	29.68
Long-Term Debt / Total Capital	50.12	38.27	28.31	21.21	18.45
Total Liabilities / Total Assets	71.69	77.84	54.46	51.56	52.09
EBIT / Interest Expense	31.27	22.55	26.39	38.13	35.01
EBITDA / Interest Expense	35.63	26.08	29.91	43.38	39.73
(EBITDA - Capex) / Interest Expense	31.62	22.34	26.7	39.51	36.52
Total Debt / EBITDA	0.97	1.41	0.86	0.73	0.63
Net Debt / EBITDA	0.83	1.31	0.49	0.52	0.52
Total Debt / (EBITDA - Capex)	1.09	1.65	0.96	0.8	0.69
Net Debt / (EBITDA - Capex)	0.94	1.52	0.55	0.57	0.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.79	4.73	8.72	6.46	10.42
Gross Profit, 1 Yr. Growth %	20.27	6.08	9.26	8.63	11.8
EBITDA, 1 Yr. Growth %	31.13	-2.5	19.92	8.89	14.05
EBITA, 1 Yr. Growth %	34.05	-3.22	21.58	8.64	14.36
EBIT, 1 Yr. Growth %	34.2	-3.57	22.07	8.45	14.3
Earnings From Cont. Operations, 1 Yr. Growth %	27.95	-8.83	24.44	5.07	19.33
Net Income, 1 Yr. Growth %	28.03	-8.83	24.44	5.07	19.33
Normalized Net Income, 1 Yr. Growth %	36.47	-4.73	23.4	10.38	13.05
Diluted EPS Before Extra, 1 Yr. Growth %	28.17	-6.63	25.28	6.06	22.59
Accounts Receivable, 1 Yr. Growth %	14.31	8.95	15.84	4.25	17.57
Inventory, 1 Yr. Growth %	28.19	36.72	3.39	0.42	-1.08
Net Property, Plant and Equip., 1 Yr. Growth %	7.18	10.87	6.46	1.42	4.99
Total Assets, 1 Yr. Growth %	6.22	12.7	18.68	1.03	1.74
Tangible Book Value, 1 Yr. Growth %	-31.11	-35.55	592.75	4.3	0.28
Common Equity, 1 Yr. Growth %	9.16	-11.78	143.87	7.46	0.63
Cash From Operations, 1 Yr. Growth %	16.59	-28.13	66.95	2.48	27.21
Capital Expenditures, 1 Yr. Growth %	11.77	24.5	-10.22	-9.51	3.1
Levered Free Cash Flow, 1 Yr. Growth %	22.37	-38.59	111.39	5.95	7.58
Unlevered Free Cash Flow, 1 Yr. Growth %	20.91	-36.16	103.83	4.84	8.02
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.58	11.54	6.7	7.58	8.42
Gross Profit, 2 Yr. CAGR %	17.63	12.95	7.66	8.94	10.2
EBITDA, 2 Yr. CAGR %	26.12	13.07	8.13	14.27	11.44
EBITA, 2 Yr. CAGR %	28.35	13.9	8.47	14.93	11.46
EBIT, 2 Yr. CAGR %	28.58	13.76	8.5	15.06	11.34
Earnings From Cont. Operations, 2 Yr. CAGR %	31.95	8.01	6.51	14.34	11.97
Net Income, 2 Yr. CAGR %	31.96	8.04	6.51	14.34	11.97
Normalized Net Income, 2 Yr. CAGR %	30.14	14.03	8.43	16.71	11.71
Diluted EPS Before Extra, 2 Yr. CAGR %	32.62	9.39	8.16	15.27	14.03
Accounts Receivable, 2 Yr. CAGR %	18.96	11.6	12.34	9.89	10.71
Inventory, 2 Yr. CAGR %	17.45	32.39	18.89	1.89	-0.33
Net Property, Plant and Equip., 2 Yr. CAGR %	6.18	9.01	8.64	3.9	3.19
Total Assets, 2 Yr. CAGR %	15.33	9.41	15.65	9.5	1.38
Tangible Book Value, 2 Yr. CAGR %	38.51	-33.37	111.3	168.8	2.27
Common Equity, 2 Yr. CAGR %	97.18	-1.86	46.68	61.89	3.99
Cash From Operations, 2 Yr. CAGR %	28.28	-8.47	9.54	30.8	14.18
Capital Expenditures, 2 Yr. CAGR %	-12.17	17.96	5.73	-9.86	-3.41
Levered Free Cash Flow, 2 Yr. CAGR %	34.4	-13.34	13.93	49.66	6.77
Unlevered Free Cash Flow, 2 Yr. CAGR %	32.45	-12.17	14.08	46.18	6.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	13.26	11.84	10.59	6.62	8.52
Gross Profit, 3 Yr. CAGR %	15.02	13.65	11.71	7.98	9.89
EBITDA, 3 Yr. CAGR %	21.74	15.75	15.31	8.38	14.2
EBITA, 3 Yr. CAGR %	23.58	16.82	16.4	8.53	14.74
EBIT, 3 Yr. CAGR %	23.79	16.82	16.46	8.48	14.81
Earnings From Cont. Operations, 3 Yr. CAGR %	25.47	16.65	13.23	6.03	15.98
Net Income, 3 Yr. CAGR %	25.48	16.66	13.25	6.03	15.98
Normalized Net Income, 3 Yr. CAGR %	25.4	17.29	17.07	9.07	15.48
Diluted EPS Before Extra, 3 Yr. CAGR %	26.39	17.98	14.45	7.45	17.66
Accounts Receivable, 3 Yr. CAGR %	16.25	15.53	13	9.58	12.39
Inventory, 3 Yr. CAGR %	15.79	23.55	21.91	12.38	0.89
Net Property, Plant and Equip., 3 Yr. CAGR %	16.58	7.72	8.15	6.18	4.26
Total Assets, 3 Yr. CAGR %	16.6	14.44	12.42	10.56	6.85
Tangible Book Value, 3 Yr. CAGR %	-4.49	7.33	45.43	66.99	93.5
Common Equity, 3 Yr. CAGR %	317.04	50.81	32.92	32.23	38.16
Cash From Operations, 3 Yr. CAGR %	23.61	5.75	11.84	7.13	29.59
Capital Expenditures, 3 Yr. CAGR %	1.08	-1.34	7.7	0.38	-5.73
Levered Free Cash Flow, 3 Yr. CAGR %	26.76	3.52	16.66	11.21	34.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	24.86	3.85	16.29	10.91	32.16
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.61	11.33	10.59	10.12	9.72
Gross Profit, 5 Yr. CAGR %	14.14	12.8	12.02	11.74	11.1
EBITDA, 5 Yr. CAGR %	19.2	15.29	16.1	15.16	13.75
EBITA, 5 Yr. CAGR %	21.14	16.71	17.3	16.06	14.4
EBIT, 5 Yr. CAGR %	21.47	16.82	17.43	16.11	14.39
Earnings From Cont. Operations, 5 Yr. CAGR %	27.39	20.87	17.52	15.72	12.72
Net Income, 5 Yr. CAGR %	27.39	20.88	17.52	15.73	12.74
Normalized Net Income, 5 Yr. CAGR %	22.74	17.69	18.31	17.06	14.89
Diluted EPS Before Extra, 5 Yr. CAGR %	28.65	22.26	18.75	16.89	14.28
Accounts Receivable, 5 Yr. CAGR %	14.71	13.53	14.67	13.24	12.08
Inventory, 5 Yr. CAGR %	11.23	17.49	17.02	14.39	12.47
Net Property, Plant and Equip., 5 Yr. CAGR %	14.15	15.17	13.34	6.18	6.14
Total Assets, 5 Yr. CAGR %	9.75	9.9	16.22	12.44	7.87
Tangible Book Value, 5 Yr. CAGR %	-6.99	-12.9	31.22	54.96	26.32
Common Equity, 5 Yr. CAGR %	44.81	62.27	174.57	55.15	20.49
Cash From Operations, 5 Yr. CAGR %	17.39	7.78	17.77	15.14	12.77
Capital Expenditures, 5 Yr. CAGR %	13.03	14.88	2.91	-4.84	3.11
Levered Free Cash Flow, 5 Yr. CAGR %	12.34	6.06	21.46	19.96	12.6
Unlevered Free Cash Flow, 5 Yr. CAGR %	11.65	5.69	20.43	19.07	12.23